Streetbeat News

Products Services

BB

BlackBerry Limited (NYSE:BB) has entered a three-year cooperative agreement with Max-Atlas to integrate BlackBerry Radar asset tracking technology into Max-Atlas' container chassis during manufacturing. This partnership aims to enhance ROI for supply chain logistics companies by providing detailed operational performance data through BlackBerry Radar's tracking solutions. The technology promises improved operational efficiencies, better customer service, and significant insights into asset utilization, safety, and security.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:11 pm

QNRX

Quoin Pharmaceuticals received FDA clearance to include teen patients in its Netherton Syndrome clinical studies, potentially expanding eligible subjects and expediting recruitment. This marks the first inclusion of non-adult subjects in such studies under an open Investigational New Drug Application.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:07 pm

F

Ford Motor Company (NYSE: F) and its dealers, through the Ford Fund, are investing $2 million in scholarships to address the shortage of automotive technicians. The Ford Auto Tech Scholarship will support 400 students in over 20 states, covering tuition, tools, living expenses, and transportation. This initiative is part of Ford's broader strategy to support the automotive industry's shift towards electrification and software integration, alongside its plans to increase electric vehicle production and create nearly 900 new jobs at its Michigan Assembly Plant.

Portfolio Pulse from Benzinga Neuro

March 04, 2024 | 1:07 pm

BABA

CGRO

JD

PGJ

Alibaba Group Holding Limited (NYSE:BABA) and JD.com Inc (NASDAQ:JD) have initiated aggressive price cuts in cloud services, signaling an intensified competition that could impact their profits. Alibaba's strategy aims to regain market share and combat rivals like Tencent Holdings Ltd (OTC:TCEHY), Baidu Inc (NASDAQ:BIDU), and JD.com. This move is part of Alibaba's broader efforts to expand its public cloud services and rejuvenate growth amid regulatory challenges and the COVID-19 pandemic's impact. Investors can gain exposure to Alibaba through Invesco Golden Dragon China ETF (NASDAQ:PGJ) and Tidal Trust II CoreValues Alpha Greater China Growth ETF (NYSE:CGRO). BABA shares traded lower by 1.05% at $73.85 in premarket trading.

Portfolio Pulse from Anusuya Lahiri

March 04, 2024 | 1:05 pm

LTRN

Lantern Pharma's AI platform, RADR, has surpassed 60 billion data points and is expected to reach over 100 billion in 2024, significantly advancing cancer therapy development. This growth enhances drug candidate development, including LP-184 and LP-284, through improved drug sensitivity, combination treatment outcomes, and biomarker data analysis. The expansion into immuno-oncology studies and molecular feature extraction from numerous molecules aims to streamline oncology drug development, making it more precise and cost-effective. Lantern's strategy has led to a substantial increase in data points since its IPO, facilitating new drug indications and accelerating development timelines.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:05 pm

ADIL

AIMD

BIVI

JAGX

LIFW

BioVie Inc. shares fell by 41.8% in pre-market trading after announcing the pricing of a public offering. Other stocks showed significant movement in pre-market trading, with Ainos, Inc., MSP Recovery, Inc., and Jaguar Health, Inc. among the top gainers. Conversely, Adial Pharmaceuticals, Inc., Caledonia Mining Corporation Plc, and Minim, Inc. were among the top losers.

Portfolio Pulse from Avi Kapoor

March 04, 2024 | 1:04 pm

VTVT

vTv Therapeutics has announced the submission of a Phase 3 study of Cadisegliatin for FDA approval, targeting treatment for patients with Type 1 Diabetes. This marks a significant step forward in the development of Cadisegliatin, potentially impacting the company's future prospects and stock performance.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:04 pm

MLTX

MoonLake Immunotherapeutics (NASDAQ:MLTX) announced it will present 24-week data from its Phase 2 MIRA trial of sonelokimab for hidradenitis suppurativa at the AAD Annual Meeting 2024. The data, showcasing the therapeutic effect of sonelokimab, marks a significant step in its development for treating this chronic skin condition. Previously, MoonLake reported positive 12-week data and further validated these findings with 24-week results, positioning sonelokimab as a promising therapy for HS.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:04 pm

BOTZ

NVDA

SMH

Nvidia Corp's CEO, Jensen Huang, predicts that artificial general intelligence (AGI) could be achieved within the next five years, emphasizing Nvidia's leading role in AI chip production. This development is crucial for AI systems like OpenAI's ChatGPT. Huang's optimism is based on the potential for AI to pass a broad range of human tests soon, although he acknowledges the challenges in replicating human cognitive processes. Nvidia's dominance in the accelerator market is highlighted, with significant growth in data center sales. Investors can gain exposure to Nvidia through the VanEck Semiconductor ETF (SMH) and the Global X Robotics & Artificial Intelligence ETF (BOTZ), which have seen substantial gains.

Portfolio Pulse from Anusuya Lahiri

March 04, 2024 | 1:02 pm

DFLI

Velociti and Dragonfly Energy announced a partnership at the American Trucking Associations Technology Maintenance Council's Annual Meeting & Transportation Technology Exhibition. This partnership allows Dragonfly Energy customers to access Velociti's Instant ROI and Velocare programs, enhancing service and support for Dragonfly's energy solutions in the trucking industry.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 12:55 pm